{"altmetric_id":15015188,"counts":{"readers":{"mendeley":50,"citeulike":0,"connotea":0},"total":{"posts_count":4},"policy":{"unique_users_count":2,"unique_users":["nap","nice"],"posts_count":4}},"citation":{"altmetric_jid":"4f6fa5e93cf058f610005a18","authors":["Dodd LE","Korn EL","Freidlin B","Jaffe CC","Rubinstein LV","Dancey J","Mooney MM","Lori E. Dodd","Edward L. Korn","Boris Freidlin","C. Carl Jaffe","Lawrence V. Rubinstein","Janet Dancey","Margaret M. Mooney"],"doi":"10.1200\/jco.2008.16.1711","endpage":"3796","first_seen_on":"2016-12-24T10:15:00+00:00","handles":[],"isbns":[],"issns":["0732-183X","1527-7755"],"issue":"22","journal":"Journal of Clinical Oncology","last_mentioned_on":1493986272,"links":["http:\/\/dx.doi.org\/10.1200\/JCO.2008.16.1711"],"pmcid":"PMC2654812","pmid":"18669467","pubdate":"2008-07-31T23:00:00+00:00","publisher":"American Society of Clinical Oncology","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"3791","subjects":["neoplasms"],"title":"Blinded Independent Central Review of Progression-Free Survival in Phase III Clinical Trials: Important Design Element or Unnecessary Expense?","type":"article","volume":"26","mendeley_url":"http:\/\/www.mendeley.com\/research\/blinded-independent-central-review-progressionfree-survival-phase-iii-clinical-trials-important-desi"},"altmetric_score":{"score":6,"score_history":{"1y":3,"6m":3,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":6},"context_for_score":{"all":{"total_number_of_other_articles":8160820,"mean":6.9113685834654,"rank":1331928,"this_scored_higher_than_pct":82,"this_scored_higher_than":6752833,"rank_type":"exact","sample_size":8160820,"percentile":82},"similar_age_3m":{"total_number_of_other_articles":264097,"mean":12.417315112686,"rank":63414,"this_scored_higher_than_pct":75,"this_scored_higher_than":200373,"rank_type":"exact","sample_size":264097,"percentile":75},"this_journal":{"total_number_of_other_articles":8740,"mean":14.574999656711,"rank":3149,"this_scored_higher_than_pct":62,"this_scored_higher_than":5444,"rank_type":"exact","sample_size":8740,"percentile":62},"similar_age_this_journal_3m":{"total_number_of_other_articles":143,"mean":37.557535211268,"rank":70,"this_scored_higher_than_pct":51,"this_scored_higher_than":73,"rank_type":"exact","sample_size":143,"percentile":51}}},"demographics":{"users":{"mendeley":{"by_status":{"Unspecified":1,"Professor > Associate Professor":3,"Librarian":3,"Student  > Doctoral Student":1,"Researcher":16,"Student  > Ph. D. Student":8,"Student  > Postgraduate":1,"Other":9,"Student  > Master":2,"Student  > Bachelor":2,"Lecturer > Senior Lecturer":1,"Professor":3},"by_discipline":{"Medicine and Dentistry":28,"Chemistry":2,"Social Sciences":1,"Decision Sciences":1,"Physics and Astronomy":1,"Agricultural and Biological Sciences":6,"Computer Science":3,"Nursing and Health Professions":1,"Mathematics":6,"Unspecified":1}}},"geo":{"mendeley":{"BE":1,"US":1,"GB":1,"DE":2,"ES":1}}},"posts":{"policy":[{"title":"A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program","url":"https:\/\/www.nap.edu\/download\/12879","license":"public","citation_ids":[15015062,15015063,14481574,1022573,1567660,899630,5802973,1022487,441918,117767,2079559,15015068,4149325,15015070,18296831,14568954,15015072,1258463,15015074,15015076,5585404,1338776,15015082,14986087,414786,15015084,3322026,8308319,16688602,18296838,185476,5741632,5810060,413368,15015086,14969312,15015090,1111972,20476742,15015093,15015094,15015097,941990,18296841,20476743,20476744,15015102,15015106,5767349,15015110,3624418,15015115,15015119,15015121,15015127,15015130,15015134,14481755,14787907,3030478,14501924,15015140,157422,1539588,1539587,2404967,15015158,4143741,15015169,1444717,15015175,15015179,15015184,14566151,1034898,15015188,6091297,20476745,15015191,15015193,15015195,15015198,14565506,14481795,15015208,14501979,15015211,15015214,1184462,702525,15015217,15015218,15015220,15015221,15015224,16688603,15015227,15015230,524541,1089474,6329188,20476747,6082718,1947504,15015242,925170,14501588,149771,15015246,15015249,15015253,15015255,16688608,5905457,15015259,15015262,173522,15015264,409284,15015272,15015284,15015292,15015295,7591021,5731357,3096223,15015305,15015309,15015313,15015317,2976405,15015321,15015325,15015328,15015333,6072231,15015337,7410380,1261624,15015346,6105109,15015353,2371613,18296844,226425,860112,15015357,3226055,2929969,228135,486914,210511,228027,18296036,15015369,3368290,4423116,18296846,15015373,15015377,18296847,613989,15015382,15015386,15015387,4768643,14969490,15015391,5818709,15015397,850081,1233068,1618930,15015403,1505039,5741287,15015409,15015414,16688609,3889888,3889888,3889888],"posted_on":"2010-01-01T00:00:00+00:00","source":{"name":"National Academies Press","description":"The US National Academies Press (NAP) was created by the National Academy of Sciences to publish the reports of the National Academies of Sciences, Engineering and Medicine, operating under a charter granted by the Congress of the United States. The NAP publishes on a wide range of topics in science, engineering, and medicine, providing authoritative information on important matters in science and health policy.","geo":{"country":"US"}},"page_url":"https:\/\/www.nap.edu\/catalog\/12879\/a-national-cancer-clinical-trials-system-for-the-21st-century","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-cff0c8e36eb58923549c1b0df34ab85b30ad70cd44d58d27031a17f80ffe3345.jpg"}},{"title":"Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary","url":"https:\/\/www.nap.edu\/download\/12535","license":"public","citation_ids":[515281,15018720,5766321,15018732,15018738,153280,227137,14485356,18308839,15018745,15018749,117722,14940002,148513,1894933,4143741,210991,1180268,20475423,15018759,5741632,15018762,1202054,15015188,1022573,1567660,14969312,15015409,1111972,1773699,15015106,101999,15018782,15018806,15018806,15018806],"posted_on":"2009-01-01T00:00:00+00:00","source":{"name":"National Academies Press","description":"The US National Academies Press (NAP) was created by the National Academy of Sciences to publish the reports of the National Academies of Sciences, Engineering and Medicine, operating under a charter granted by the Congress of the United States. The NAP publishes on a wide range of topics in science, engineering, and medicine, providing authoritative information on important matters in science and health policy.","geo":{"country":"US"}},"page_url":"https:\/\/www.nap.edu\/catalog\/12535\/multi-center-phase-iii-clinical-trials-and-nci-cooperative-groups","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-65f4d16fa9392a22a6decf60399729c6fe360d9761b64a61b8066a7508911d8c.jpg"}},{"title":"Implementing a National Cancer Clinical Trials System for the 21st Century: Second Workshop Summary","url":"https:\/\/www.nap.edu\/download\/18362","license":"public","citation_ids":[15052895,14577996,581420,1398010,1469811,2828898,615942,15015188,15052896,15052897,1198988,15052901,15052901,15052901],"posted_on":"2013-01-01T00:00:00+00:00","source":{"name":"National Academies Press","description":"The US National Academies Press (NAP) was created by the National Academy of Sciences to publish the reports of the National Academies of Sciences, Engineering and Medicine, operating under a charter granted by the Congress of the United States. The NAP publishes on a wide range of topics in science, engineering, and medicine, providing authoritative information on important matters in science and health policy.","geo":{"country":"US"}},"page_url":"https:\/\/www.nap.edu\/catalog\/18362\/implementing-a-national-cancer-clinical-trials-system-for-the-21st-century","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-146fbe03d9c84340207fae778a56677a13553f44a657d144f7a0c6d77682bf1b.jpg"}},{"title":"Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease: Committee papers","url":"https:\/\/www.nice.org.uk\/guidance\/ta449\/documents\/committee-papers","license":"public","citation_ids":[21719232,4323582,21719241,1686227,210723,3261360,2072138,15015188,4481773,185091,4881576,185090,2955948,21719255,21719262,21719267,469143,3760948,4543729,1388591,21719274,1631594,21719277,2414612,6155710,4039888,9683320,14978118,6235398,4301468,1209654,1324014,6005025,22918193,3555764,15781629,658423,21719313,21719317,2412976,1793033,1587282,21719322,2540962,5066855,4399764,21719325,21719328,4794675,1212900,4213785,21719335,2750577,525442,16018645,21719337,2470187,21719344,2054552,213175,16018637,2189646,4138276,4806523,4138278,7590960,21719366,11969334,4042729,4481774,16862636,21719369,21719372,1978380,20584352,21719378,21719379,21719384,1201707,1405028,21719396,6284726,21719398,21719401,19658265,21719405,13193624,10950926,3322234,4150556],"posted_on":"2017-05-05T12:11:12+00:00","source":{"name":"National Institute for Health and Care Excellence","description":"The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.","geo":{"country":"GB"}},"page_url":"https:\/\/www.nice.org.uk\/guidance\/ta449\/evidence","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-5dd3598af8821e9796e733d194eca7a04ccb6ee33da049ae0bb78759a5007c19.jpg"}}]}}